Symcel
Symcel, the global leader in biocalorimetry, has a bold vision to redefine sterility testing for cell and gene therapies. By repurposing a microcalorimeter to measure microbial activity in real time, the Symcel calScreener+™ can detect phenotypic contamination earlier than any other system available. With significantly higher sensitivity than traditional sterility tests, sterility testing timelines can be reduced to under three days, a 70% decrease on the current gold standard.
For you as a cell and gene therapy producer, this breakthrough is a potential game-changer. It allows you to mitigate contamination risks, eliminates the issue of product matrices, simplifies manufacturing processes, and slashes your time-to-market.
With our global headquarters at the Karolinska Institute in Stockholm, we are a passionate, multidisciplinary team of 20 nationalities and with 15 PhDs.
Join us in transforming sterility testing.